Regulatory

USFDA concludes inspection at Zydus Life's SEZ II Ahmedabad plant with 1 observation

There were no data integrity related observations

  • By IPP Bureau | September 29, 2026

Zydus informed that the USFDA conducted cGMP inspection for the company’s manufacturing plant at SEZ II, Ahmedabad. The inspection was conducted from 21st to 28th September 2026. 

The inspection closed with one observation. There were no data integrity related observations. The company will closely work with the USFDA to address the observation expeditiously.

Upcoming E-conference

ChemPharma R&D Summit 2026

October 27, 2026

Other Related stories

Startup

Digitization